|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.85 CHF | +5.57% |
|
-1.88% | +23.59% |
| 10:41am | DOCMORRIS : Warburg Research reiterates its Buy rating | ZD |
| 09:05am | DOCMORRIS : UBS reaffirms its Sell rating | ZD |
EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase Under the following link, you will find a press release of the Zur Rose Group. https://zurrosegroup.com/websites/zurrosegroup/English/2015/acquisition-medpex.html
End of Corporate News |
| Language: | English |
| Company: | Zur Rose Group AG |
| Walzmühlestrasse 60 | |
| 8500 Frauenfeld | |
| Switzerland | |
| Phone: | +41 52 724 08 14 |
| Internet: | www.zurrosegroup.com |
| ISIN: | CH0042615283 |
| Listed: | SIX Swiss Exchange |
| End of News | EQS Group News Service |
753551 03.12.2018
| 1st Jan change | Capi. | |
|---|---|---|
| +23.59% | 1.13B | |
| -32.59% | 15.23B | |
| -40.54% | 9.9B | |
| -4.53% | 6.83B | |
| +9.14% | 6.1B | |
| -38.21% | 5.59B | |
| +5.40% | 5B | |
| +49.08% | 4.21B | |
| -11.42% | 3.65B | |
| -11.73% | 3.46B |
DOCMORRIS AG 
